They can be segregated into 5 classes of Immunoglobulin; IgG, IgM, IgE, IgA and IgD; their class is determined by the type of heavy chain in the antibody with corresponding lower-case Greek letters (γ, μ, ε, α,and δ respectively). Each of them has a different distribution in the body. IgM and IgA are multimeric. The other three are monomeric antibodies. IgA exist as both multimeric and monomeric antibody in different tissues of the body. The classes differ in their structure and function (except IgD which has no clear function).
Antibody molecules are in the shape of a Y, and all consist of three parts that are connected together by disulphide bonds in order to form this Y shape. Antibodies are also made up of a two polypeptide chains; a heavy chain and a light chain. All immunoglobulin molecules contain heavy and light chains that are identical, giving rise to two identical antigen-binding sites. The light chains of the immunoglobulin molecule are categorised as lambda or kappa. Any of the light chains can be associated with any heavy chains but one immunoglobulin molecule can only have either kappa or lambda chain, not both. The synthesis of either kappa or lambda light chains is known as isotype exclusion which occurs as a consequence of allelic exlusion. The stem of the Y is a constant region composed of only heavy chains, this is known as the Fc unit and determines the function of the antibody. The ends of the arms of the Y form variable regions composed of heavy and light chains, these are known as the Fab units. The constant regions can be used to distinguish between the 5 classes of immunoglobulins while the variable regions 'vary' between different antibody molecules. This variable region binds to the specific antigens and is made up of six hypervariable loops. Three of these come from VL (variable light-chain) and three from the VH (variable heavy- chain) regions. Between these regions exists more stable FR (framework regions) which make up the rest of the variable region. They provide stability to the antibody and when folded into secondary structure provide a scaffold to anchor the HV regions in place. Specificity depends on the amino acid sequence in the hypervariable region. In contrast, the CH (constant heavy-chain) is used to interact with effector cells and complement.
Antigen-binding and recognition
The VL and VH domains are highly variable in their amino acid sequence forming a unique antigen-binding site or paratope. The hypervariable regions that form the antigen-binding site are therefore also called complementarity-determining regions (CDRs). Analysis of the three-dimensional structure of Abs performed by X-ray crystallographic techniques propose that the mechanism for antigen-binding is the induced fit mechanism at the CDR.
The hinge region is a segment of the CH chains. Since Ags are able to have epitopes at non-adjacent sites, the hinge region is critical for the flexibility of the Ab, thus allowing the two antigen-binding sites to act independently.
Through amino acid sequence analysis, homology regions were found which are referred to as 'homology domains'. The L chain comprises 2 domains and the H chain can have either 4 or 5 domains. Each domain is around 110 amino acids in length, comprised of two beta sheets, linked by a disulphide bridge. It is worth noting domains are also paired - folded units within the protein.
- ↑ Janeway CA Jr, Travers P, Walport M, et al.(2001) Immunobiology: The Immune System in Health and Disease. 5th edition, New York, Garland Science, Figure 3.1.
- ↑ Peter Wood. Understanding Immunology. Third edition. Pearson Education Limited, England( 2011
- ↑ Janeway C, Immunobiology: The Immune System in Health and Disease 2001, 5th Edition, New York: Garland Science, Chapter 5 Page 7-10.
- ↑ Klaus D. Elgert Immunology: Understanding the Immune System 2nd edition (2009) New Jersey; John Wiley and Sons Inc
- ↑ Male D, Brostoff J, Roth DB, Roitt IM. Immunology, 8th Edn. London Elsevier Health Sciences UK; 2013: p9.
- ↑ Abbas AK, Lichtman AH, Pillai S. Cellular and Molecular Immunology, 8th Edn. Philadelphia: Elsevier Saunders; 2015: p88-94.
- ↑ Newsholme EA, Leech TR. Functional Biochemistry in Health and Disease. Chichester, UK: Wiley-Blackwell; 2010: p383-386.